4.4 Article

Candidate susceptibility variants for esophageal squamous cell carcinoma

Journal

GENES CHROMOSOMES & CANCER
Volume 56, Issue 6, Pages 453-459

Publisher

WILEY
DOI: 10.1002/gcc.22448

Keywords

-

Ask authors/readers for more resources

Esophageal cancer is common worldwide, and often fatal. The major histological subtype is esophageal squamous cell carcinoma (ESCC). ESCC shows familial aggregation and high heritability. Mutations in RHBDF2 cause tylosis, a very rare disorder characterized by high life-time risk of ESCC, but no other well-established predisposition genes have been identified. To identify candidate susceptibility variants for ESCC we utilized the Population Information System and the Finnish cancer registry to find study materials by clustering ESCC patients by family name at birth and municipality at birth. We collected archival tissue material and exome sequenced a total of 30 ESCC cases. We prioritized shared, deleterious and rare variants that were significantly enriched in our sample set compared to Finnish and population subset specific controls. Six variants passed filtering, the most frequent being a nonsense mutation in DNAH9 (p.Tyr1573Ter) found in four unrelated patients. DNAH9 has been reported to be frequently lost in ESCC tumors. In this study, one patient's tumor showed loss of the wild type allele of DNAH9 suggesting a tumor suppressive function. A missense variant in GKAP1 was shared by three patients, and missense variants in BAG1, NFX1, FUK, and DDOST by two each. EP300 which has previously been implicated in the genesis of ESCC had a missense variant segregating in three affected individuals in a single family. If validated in independent patient sets, these variants could serve as a tool towards prevention and early diagnosis of ESCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Novel germline variant in the histone demethylase and transcription regulator KDM4C induces a multi-cancer phenotype

Riku Katainen, Iikki Donner, Maritta Raisanen, Davide Berta, Anna Kuosmanen, Eevi Kaasinen, Marja Hietala, Lauri A. Aaltonen

Summary: This study identified a variant in the KDM4C gene that was associated with malignancy in an early-onset multi-cancer family, indicating a potential causal role of this mutation in cancer predisposition. Further analysis revealed dysregulation of H3K9 trimethylation and KDM4C-associated genes in individuals carrying the variant, supporting the hypothesis of its pathogenicity.

JOURNAL OF MEDICAL GENETICS (2022)

Article Peripheral Vascular Disease

Next-generation sequencing in a large pedigree segregating visceral artery aneurysms suggests potential role of COL4A1/COL4A2 in disease etiology

Iikki Donner, Lauri J. Sipila, Roosa-Maria Plaketti, Anna Kuosmanen, Linda Forsstrom, Riku Katainen, Outi Kuismin, Mervi Aavikko, Pekka Romsi, Juho Kariniemi, Lauri A. Aaltonen

Summary: This study presents a family with seven members affected by visceral artery aneurysms and one member affected by a visceral artery pseudoaneurysm. Through exome and whole-genome sequencing, a possible non-coding variant was identified, suggesting COL4A1 and COL4A2 as strong candidates for VAA susceptibility genes.

VASCULAR (2022)

Article Pathology

Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas

Terhi Ahvenainen, Jaana Kaukomaa, Kati Kampjarvi, Outi Uimari, Anne Ahtikoski, Netta Makinen, Oskari Heikinheimo, Lauri A. Aaltonen, Auli Karhu, Ralf Butzow, Pia Vahteristo

Summary: This study analyzed three antibodies (2SC, AKR1B10, and FH) as potential biomarkers to differentiate hereditary leiomyomatosis and renal cell cancer. The results showed that 2SC and AKR1B10 had high accuracy and sensitivity, making them useful tools for screening and diagnosis.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Article Pathology

Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor Comparison to Molecular Subtypes of Uterine Leiomyoma

Heli Kuisma, Vilja Jokinen, Annukka Pasanen, Oskari Heikinheimo, Auli Karhu, Niko Valimaki, Lauri Aaltonen, Ralf Butzow

Summary: Uterine leiomyoma (UL) and uterine inflammatory myofibroblastic tumor (IMT) are difficult to differentiate based on morphology alone. Some IMT patients have gene expression profiles similar to UL, suggesting that UL diagnosis may be more appropriate for these IMTs.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Article Biochemistry & Molecular Biology

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate

Asa Kolterud, Niko Valimaki, Heli Kuisma, Joonatan Patomo, Sini T. Ilves, Netta Makinen, Jaana Kaukomaa, Kimmo Palin, Eevi Kaasinen, Auli Karhu, Annukka Pasanen, Ralf Butzow, Oskari Heikinheimo, Helena Kopp Kallner, Lauri A. Aaltonen

Summary: This study found that the treatment response of uterine fibroids is influenced by molecular subclasses, with MED12 mutant fibroids having a higher chance of shrinking after ulipristal acetate treatment compared to HMGA2 driven fibroids. Gene expression and DNA methylation analyses also revealed subclass specific differences in progesterone receptor signaling. These findings highlight the importance of considering genetic subclasses in evaluating uterine fibroid therapies.

HUMAN MOLECULAR GENETICS (2023)

Article Multidisciplinary Sciences

Sex-specific familial aggregation of cancers in Finland

Lauri J. Sipila, Karri Seppa, Mervi Aavikko, Janne Ravantti, Sanna Heikkinen, Lauri A. Aaltonen, Janne Pitkaniemi

Summary: This study explored the impact of sex on familial aggregation of cancers and found that familial cancer risks were similar between sexes. However, certain families showed exceptionally high cumulative cancer incidence, particularly for stomach cancer, colon cancer, thyroid cancer, and chronic lymphocytic leukemia. The atypical sex-specific aggregation in these families poses challenges in explaining with current knowledge and warrants further exploration.

SCIENTIFIC REPORTS (2022)

Article Genetics & Heredity

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

Ceres Fernandez-Rozadilla, Maria Timofeeva, Zhishan Chen, Philip Law, Minta Thomas, Stephanie Bien, Virginia Diez-Obrero, Li Li, Juan Fernandez-Tajes, Claire Palles, Kitty Sherwood, Sarah Harris, Victoria Svinti, Kevin McDonnell, Susan Farrington, James Studd, Peter Vaughan-Shaw, Xiao-ou Shu, Jirong Long, Qiuyin Cai, Xingyi Guo, Yingchang Lu, Peter Scacheri, James Studd, Jeroen Huyghe, Tabitha Harrison, David Shibata, Christopher Haiman, Mathew Devall, Fredrick Schumacher, Marilena Melas, Gad Rennert, Mireia Obon-Santacana, Vicente Martin-Sanchez, Ferran Moratalla-Navarro, Jae Hwan Oh, Jeongseon Kim, Sun Ha Jee, Keum Ji Jung, Sun-Seog Kweon, Min-Ho Shin, Aesun Shin, Yoon-Ok Ahn, Dong-Hyun Kim, Isao Oze, Wanqing Wen, Keitaro Matsuo, Koichi Matsuda, Chizu Tanikawa, Zefang Ren, Yu-Tang Gao, Wei-Hua Jia, John Potter, Mark Jenkins, Aung Ko Win, Rish Pai, Jane Figueiredo, Robert Haile, Steven Gallinger, Michael Woods, Polly Newcomb, David Shibata, Jeremy Cheadle, Richard Kaplan, Timothy Maughan, Rachel Kerr, David Kerr, Iva Kirac, Jan Boehm, Lukka-Pekka Mecklin, Pekka Jousilahti, Paul Knekt, Lauri Aaltonen, Harri Rissanen, Eero Pukkala, Johan Eriksson, Tatiana Cajuso, Ulrika Hanninen, Johanna Kondelin, Kimmo Palin, Tomas Tanskanen, Laura Renkonen-Sinisalo, Brent Zanke, Satu Mannisto, Demetrius Albanes, Stephanie Weinstein, Edward Ruiz-Narvaez, Julie Palmer, Daniel Buchanan, Elizabeth Platz, Kala Visvanathan, Cornelia Ulrich, Erin Siegel, Stefanie Brezina, Andrea Gsur, Peter Campbell, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, Martha Slattery, John Potter, Konstantinos Tsilidis, Matthias Schulze, Marc Gunter, Neil Murphy, Antoni Castells, Sergi Castellvi-Bel, Leticia Moreira, Volker Arndt, Anna Shcherbina, Mariana Stern, Bens Pardamean, Timothy Bishop, Graham Giles, Melissa Southey, Gregory Idos, Kevin McDonnell, Zomoroda Abu-Ful, Joel Greenson, Katerina Shulman, Flavio Lejbkowicz, Kenneth Offit, Yu-Ru Su, Robert Steinfelder, Temitope Keku, Bethany van Guelpen, Thomas Hudson, Heather Hampel, Rachel Pearlman, Sonja Berndt, Richard Hayes, Marie Elena Martinez, Sushma Thomas, Douglas Corley, Paul Pharoah, Susanna Larsson, Yun Yen, Heinz-Josef Lenz, Emily White, Li Li, Kimberly Doheny, Elizabeth Pugh, Tameka Shelford, Andrew Chan, Marcia Cruz-Correa, Annika Lindblom, David Shibata, Amit Joshi, Clemens Schafmayer, Peter Scacheri, Anshul Kundaje, Deborah Nickerson, Robert Schoen, Jochen Hampe, Zsofia Stadler, Pavel Vodicka, Ludmila Vodickova, Veronika Vymetalkova, Nickolas Papadopoulos, Chistopher Edlund, William Gauderman, Duncan Thomas, David Shibata, Amanda Toland, Sanford Markowitz, Andre Kim, Stephen Gruber, Franzel van Duijnhoven, Edith Feskens, Lori Sakoda, Manuela Gago-Dominguez, Alicja Wolk, Alessio Naccarati, Barbara Pardini, Liesel FitzGerald, Soo Chin Lee, Shuji Ogino, Stephanie Bien, Charles Kooperberg, Christopher Li, Yi Lin, Ross Prentice, Conghui Qu, Stephane Bezieau, Catherine Tangen, Elaine Mardis, Taiki Yamaji, Norie Sawada, Motoki Iwasaki, Christopher Haiman, Loic Le Marchand, Anna Wu, Chenxu Qu, Caroline McNeil, Gerhard Coetzee, Caroline Hayward, Ian Deary, Sarah Harris, Evropi Theodoratou, Stuart Reid, Marion Walker, Li Yin Ooi, Victor Moreno, Graham Casey, Stephen Gruber, Ian Tomlinson, Wei Zheng, Malcolm Dunlop, Richard Houlston, Ulrike Peters

Summary: This study identified 205 independent risk associations for colorectal cancer through a genome-wide association study meta-analysis. Transcriptome and methylome analysis further revealed 53 risk associations. These findings provide insights into the genetic and molecular mechanisms of colorectal oncogenesis and suggest potential targets for new treatment and prevention strategies.

NATURE GENETICS (2023)

Article Oncology

Vitamin C boosts DNA demethylation in TET2 mutation carriers

Aurora Taira, Kimmo Palin, Anna Kuosmanen, Niko Valimaki, Outi Kuittinen, Outi Kuismin, Eevi Kaasinen, Kristiina Rajamaki, Lauri A. Aaltonen

Summary: Recent studies have shown that vitamin C can enhance the demethylation activity of the TET2 gene and reduce DNA hypermethylation. This suggests that vitamin C may play a role in preventing hematological malignancies in individuals with TET2 dysfunction.

CLINICAL EPIGENETICS (2023)

Article Otorhinolaryngology

Sudden Hearing Loss Following Vaccination Against COVID-19

Tuomo A. Nieminen, Ilkka Kivekas, Miia Artama, Hanna Nohynek, Jarno Kujansivu, Petteri Hovi

Summary: A Finnish study found no evidence of an increased risk of sudden hearing loss following COVID-19 vaccination. The study adjusted for potential confounding factors and relied on specialized care diagnosis codes.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2023)

Article Genetics & Heredity

Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas

Niko Valimaki, Vilja Jokinen, Tatiana Cajuso, Heli Kuisma, Aurora Taira, Olivia Dagnaud, Sini Ilves, Jaana Kaukomaa, Annukka Pasanen, Kimmo Palin, Oskari Heikinheimo, Ralf Butzow, Lauri A. Aaltonen, Auli Karhu

Summary: Uterine leiomyomas (ULs) are common benign smooth muscle tumors in premenopausal women. Variants in genes encoding subunits of the SRCAP complex (YEATS4, ZNHIT1, DMAP1, and ACTL6A) are significantly associated with ULs. These variants are linked to earlier diagnosis and hysterectomy. These findings establish the inactivation of SRCAP complex genes as a major contributor to moderate-penetrance UL predisposition.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Article Multidisciplinary Sciences

Trends and factors associated with initiation of HIV treatment among PLHIV in Jamaica, 2015-2019

Anya Cushnie, Ralf Reintjes, J. Peter Figueroa, Miia Artama

Summary: This study examines the trends and factors associated with HIV treatment uptake in Jamaica. The results show that while same day initiation has increased, it remains low. To achieve UNAIDS targets, there is a need to increase the number of PLHIV on treatment in Jamaica.

PLOS ONE (2023)

Article Multidisciplinary Sciences

Incidence of sinus thrombosis with thrombocytopenia-A nation-wide register study

Petteri Hovi, Arto A. Palmu, Tuomo A. Nieminen, Miia Artama, Jukka Jokinen, Esa Ruokokoski, Riitta Lassila, Hanna Nohynek, Terhi Kilpi

Summary: Reports of serious cerebral venous sinus thrombosis (CVST) with thrombocytopenia have emerged following COVID-19 vaccinations. A study in Finland found a very low proportion of CVST with thrombocytopenia cases within four weeks after receiving the AstraZeneca vaccine, while no cases were found following mRNA vaccine doses. Accurate estimation of the baseline incidence is crucial for evaluating the benefit-risk of any vaccination program.

PLOS ONE (2023)

Article Gastroenterology & Hepatology

Genome-Wide Association Study Identifies 4 Novel Risk Loci for Small Intestinal Neuroendocrine Tumors Including a Missense Mutation in LGR5

Anil K. Giri, Mervi Aavikko, Linnea Wartiovaara, Toni Lemmetyinen, Juha Karjalainen, Juha Mehtonen, Kimmo Palin, Niko Valimaki, Max Tamlander, Riikka Saikkonen, Auli Karhu, Ekaterina Morgunova, Benjamin Sun, Heiko Runz, Priit Palta, Shuang Luo, Heikki Joensuu, Tomi P. Makela, Iiro Kostiainen, Camilla Schalin-Jantti, Aarno FinnGen, Aarno Palotie, Lauri A. Aaltonen, Saara Ollila, Mark J. Daly

Summary: This study is the largest genome-wide association study on small intestinal neuroendocrine tumors (SI-NETs) to date, and it identified 6 significant loci associated with SI-NET risk. Four of these loci are novel, and one of the top hits is a missense variant in the LGR5 gene, a marker of adult intestinal stem cells.

GASTROENTEROLOGY (2023)

Article Genetics & Heredity

Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping

Prima Sanjaya, Katri Maljanen, Riku Katainen, Sebastian A. Waszak, Lauri O. Aaltonen, Oliver Stegle, Jan Korbel, Esa Pitkaenen

Summary: This study introduces a deep neural network called Mutation-Attention (MuAt) that can learn representations of simple and complex somatic alterations for prediction of tumour types and subtypes. By utilizing the attention mechanism on individual mutations, MuAt models achieved high prediction accuracy on whole genomes and exomes. Furthermore, MuAt models were able to learn clinically and biologically relevant tumour entities, potentially impacting precision cancer medicine.

GENOME MEDICINE (2023)

No Data Available